Renal cell carcinoma also exhibits some sensitivity to mtor inhibitors, likely because of the importance of mtor signalling in the expression of Hif1A (hypoxia inducible factor 1, alpha subunit), a key player in angiogenesis and the growth of renal tumours11,12. This evidence concerns the gene MTOR and renal cell carcinoma.